Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2482
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients ; volume:13 ; number:2 ; day:8 ; month:10 ; year:2013 ; pages:1-5 ; date:10.2013
BMC surgery ; 13, Heft 2 (8.10.2013), 1-5, 10.2013
- Creator
-
Guerra, Anna
- Contributor
-
Di Crescenzo, Vincenzo
Garzi, Alfredo
Cinelli, Mariapia
Carlomagno, Chiara
Pepe, Stefano
Zeppa, Pio
Tonacchera, Massimo
Vitale, Mario
SpringerLink (Online service)
- DOI
-
10.1186/1471-2482-13-S2-S37
- URN
-
urn:nbn:de:1111-2016072927516
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guerra, Anna
- Di Crescenzo, Vincenzo
- Garzi, Alfredo
- Cinelli, Mariapia
- Carlomagno, Chiara
- Pepe, Stefano
- Zeppa, Pio
- Tonacchera, Massimo
- Vitale, Mario
- SpringerLink (Online service)
Other Objects (12)
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells